跳至主要内容
临床试验/NCT07186491
NCT07186491尚未招募不适用

Exploring the Application of a Wearable Ultrasound (US) Patch Device for Breast Imaging

Massachusetts General Hospital1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2026年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
50
试验地点
1
主要终点
Sensitivity and Specificity of the Wearable Ultrasound Patch for Detecting Breast Lesions

研究概览

简要总结

The goal of this clinical trial is to learn if a wearable ultrasound (US) patch can provide reliable whole-breast imaging and accurately detect breast lesions in patients undergoing breast health evaluation. The main questions it aims to answer are:

  • How well does the US-patch detect breast lesions in breasts of different shapes, sizes, and tissue densities?
  • Are there any side effects or discomfort from using the US-patch?

Researchers will compare results from the wearable US-patch to conventional ultrasound to see if the patch provides specific and sensitive findings.

Participants will:

  • Have breast imaging performed with the wearable US-patch, which is applied directly to the breast and secured with a sports bra.
  • Use a guiding software application that helps correctly position the patch.
  • Complete the imaging session in less than 15 minutes, performed by study personnel.

详细描述

This study is designed to evaluate the performance, safety, and reliability of a newly developed conformable wearable ultrasound (US) patch for whole-breast imaging. The device is a flexible, skin-adherent transducer array that provides real-time, three-dimensional imaging of the breast. The primary goal of the study is to assess the diagnostic accuracy of the US-patch device in detecting breast lesions across a variety of breast shapes, sizes, and tissue densities, using conventional handheld ultrasound as the reference standard (ground truth).

Investigators plan to enroll 50 patients over a 12-month period who are undergoing breast health evaluation and either have had or are scheduled for conventional breast ultrasound within one month. Participants will undergo imaging with the US-patch device, which will be applied directly to the breast and secured with a sports bra to maintain consistent contact. The imaging session will take less than 15 minutes and will be performed by trained study personnel.

The diagnostic performance of the US-patch device will be assessed by calculating sensitivity and specificity for breast lesion detection, using true positive, false positive, true negative, and false negative determinations based on radiologist interpretation. Statistical analyses will be performed on a per-lesion basis. Findings will be compared to conventional ultrasound results to determine the accuracy and reliability of the device.

Safety and tolerability will also be evaluated. All participants will be contacted by telephone one week after the imaging session to assess for any delayed adverse effects. Participants who return for follow-up visits within the one-year study period will undergo repeat US-patch imaging, and any adverse events, discomfort, or skin irritation will be documented.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
Female
接受健康志愿者
是

入选标准

  • •Investigators will exclusively enroll patients who have undergone conventional US imaging for their breasts within the past month or are scheduled to undergo it within the upcoming month.
  • •Patients with a history of breast cancer or prior breast surgery can also be enrolled
  • •Female gender
  • •Ages between 18 and 85 years old
  • •Being able to understand, communicate, give valid consent to the study, and be understood by researchers

排除标准

  • •Having significant health problems (such as chronic or acute cardiovascular diseases, skin diseases) physical and/or behavioral health disabilities limiting participants' ability to follow directions and complete research related activities.
  • •Being pregnant
  • •Not having intact, healthy breast skin (having open scars or wounds around the location of the breast)

研究组 & 干预措施

Breast Imaging with Wearable Ultrasound Device

Experimental

Participants in this arm will undergo breast imaging using the wearable ultrasound (US) patch device. The patch is a flexible, skin-adherent transducer array designed to provide whole-breast 3D ultrasound imaging. It will be applied directly to the breast with coupling gel and secured with a sports bra to maintain contact. Imaging will be completed in less than 15 minutes, and results will be compared with conventional ultrasound, which serves as the reference standard.

干预措施: Wearable Ultrasound Patch (Device)

结局指标

主要结局

Sensitivity and Specificity of the Wearable Ultrasound Patch for Detecting Breast Lesions

时间窗: From enrollment to 1 week after initial imaging

The primary outcome will assess the diagnostic accuracy of the conformable US-patch device by comparing its breast lesion detection results to conventional handheld ultrasound (reference standard). Sensitivity and specificity will be calculated per lesion using true positive, false positive, true negative, and false negative determinations based on radiologist interpretation. This metric will serve as the main assessment of the device's performance in detecting breast anomalies across a range of breast shapes, sizes, and tissue densities.

次要结局

  • Safety of the Wearable Ultrasound Patch(From enrollment to 1 week after the initial US-patch imaging, and at any follow-up visit within the 12-month study period.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Tolga Ozmen, MD

Breast Surgery, Surgical Oncology

Massachusetts General Hospital

研究点 (1)

Loading locations...

相似试验